Citation: D. Butzbach et al., Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry, INT J RAD O, 51(5), 2001, pp. 1196-1199
Authors:
Chen, CT
Valicenti, RK
Lu, JD
Derose, T
Dicker, AP
Strup, SE
Mulholland, SG
Hirsch, IH
McGinnis, DE
Gomella, LG
Citation: Ct. Chen et al., Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?, INT J RAD O, 50(3), 2001, pp. 591-595
Authors:
Cvetkovic, D
Movsas, B
Dicker, AP
Hanlon, AL
Greenberg, RE
Chapman, JD
Hanks, GE
Tricoli, JV
Citation: D. Cvetkovic et al., Increased hypoxia correlates with increased expression of the angiogenesismarker vascular endothelial growth factor in human prostate cancer, UROLOGY, 57(4), 2001, pp. 821-825
Citation: Fm. Waterman et Ap. Dicker, The impact of postimplant edema on the urethral dose in prostate brachytherapy, INT J RAD O, 47(3), 2000, pp. 661-664
Citation: Fm. Waterman et Ap. Dicker, Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan, MED PHYS, 27(3), 2000, pp. 448-451
Authors:
Yue, N
Chen, Z
Peschel, R
Dicker, AP
Waterman, FM
Nath, R
Citation: N. Yue et al., Optimum timing for image-based dose evaluation of I-125 and (PD)-P-103 prostate seed implants, INT J RAD O, 45(4), 1999, pp. 1063-1072
Authors:
Valicenti, RK
Gomella, LG
Ismail, M
Strup, SE
Mulholland, SG
Dicker, AP
Petersen, RO
Newschaffer, CJ
Citation: Rk. Valicenti et al., The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: A matched-pair analysis, INT J RAD O, 45(1), 1999, pp. 53-58
Authors:
Valicenti, RK
Sweet, JW
Hauck, WW
Hudes, RS
Lee, T
Dicker, AP
Waterman, FM
Anne, PR
Corn, BW
Galvin, JM
Citation: Rk. Valicenti et al., Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer, INT J RAD O, 44(4), 1999, pp. 931-935
Authors:
Yue, N
Dicker, AP
Corn, BW
Nath, R
Waterman, FM
Citation: N. Yue et al., A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of I-125 or Pd-103 seed implant of prostate, INT J RAD O, 43(2), 1999, pp. 447-454